Paget’s disease of the bone is a rare condition that causes weak, misshapen bones. It’s chronic, meaning it’s a long-term disorder. However, when treated early, bone deformities and pain can be ...

Baylor College of Medicine has received new funding from the National Institutes of Health for two consortia in the Rare Diseases Clinical Research Network: $7.4 million over five years to renew the ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on myCME.com. Organ transplantation has become a fairly common and effective modality ...

Ultragenyx Pharmaceutical said on Monday that its ‍experimental drug for a type of genetic bone disease did not meet the main goal ‌in late-stage ‌studies. The company was testing the treatment called ...

Brittle bone disease (osteogenesis imperfecta) is an inherited genetic condition that causes bone weakness. It can increase a person’s risk of fractures and other medical complications. A person with ...

With a pair of Phase III trial flops, Ultragenyx will explore cost reductions as analysts turn attention to an upcoming ...

Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...